Intellia Therapeutics ($NTLA)

Description

Develops gene-editing medicines for serious diseases. Its clinical programmes use CRISPR delivered inside the body to treat inherited protein disorders and recurrent swelling.

Intellia Therapeutics ($NTLA) is located in the Boston ecosystem.

Related

• Vertex Pharmaceuticals ($VRTX)Discovers, develops, and produces medicines for people with serious diseases, while offering treatment support and information about…
• Verve TherapeuticsSingle-course gene-editing therapies for cardiovascular disease. Cambridge MA; CRISPR-based PCSK9 + ANGPTL3 programs.
• Moderna ($MRNA)Develops mRNA medicines using a platform for designing, researching, and testing mRNA, with a focus on addressing infectious and serious…
• Beam Therapeutics ($BEAM)Develops investigational base-editing genetic medicines and delivery technologies, including electroporation, nonviral, and viral methods,…
• Life BiosciencesDevelops epigenetic restoration therapies intended to rejuvenate cells and treat age-related diseases, with an initial clinical trial…
• OpenwaterDevelops low-cost medical hardware and software using light, sound, and electromagnetics in the body, aiming to treat diseases and support…
• CRISPR Therapeutics ($CRSP)CRISPR Therapeutics develops CRISPR-based gene-editing therapies across hemoglobinopathies, oncology, diabetes, and cardiovascular disease,…
• Vertex Pharmaceuticals (San Diego)Discovers, develops, and produces medicines for serious diseases, while providing medical information, patient support, and clinical trial…
• Editas Medicine ($EDIT)Develops CRISPR-based gene editing medicines, including in vivo approaches, for people with serious diseases where modifying genes may…
• Krystal Biotech ($KRYS)Develops and delivers redosable genetic medicines, including VYJUVEK for dystrophic epidermolysis bullosa, using engineered HSV-1 vectors…
• Merck Cambridge Discovery ($MRK)Develops medicines and vaccines through research, clinical trials, and publications, focusing on diseases including cancer, infectious,…
• Relay Therapeutics ($RLAY)Develops small molecule medicines using computational and experimental protein-motion analysis, targeting previously hard-to-drug precision…